 Monsanto will be first to sell a revolutionary type of arthritis medication, but its battle with Merck & Co. in the high stakes painkiller drug wars is far from over.
These drugs will treat the pain and inflammation associated with arthritis without the stomach problems associated with today's over-the-counter and prescription drugs, the companies say.
Some analysts predict Celebra will outsell Viagra, the lucrative Pfizer Inc. impotency treatment that became the fastest-selling drug in history its first month.
We spend as much on unproven remedies for this disease as we do on research, says Dr. Bernard Rubin, chief of rheumatology at the University of North Texas Health Science Center in Fort Worth.
The study represents a new wave in academic medicine : the including the gold standard of medical research, the placebo, or fake therapy, as to test alternative therapies, from ginkgo biloba to shark cartilage to a mystical Chinese healing art known as qi gong.
The arthritis drugs, those in testing and those on the market, are being showcased this week at the American College of Rheumatology meeting in San Diego, where each company is trying to show arthritis doctors why its treatment works best.
 A third new drug for people suffering from the pain of arthritis has been approved by federal regulators.
